5 Einträge gefunden

1. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

   1. Kluth, Martina
   2. Hesse, Jana
   3. Heinl, Anna
   4. Krohn, Antje
   5. Steurer, Stefan
   6. Sirma, Hüseyin
   7. Simon, Ronald

   2013 - Forschungsinformationssystem des UKE
2. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederik
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem des UKE
3. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers

   1. Raeder, Maria B
   2. Birkeland, Even
   3. Trovik, Jone
   4. Krakstad, Camilla
   5. Shehata, Shyemaa
   6. Schumacher, Steven
   7. Zack, Travis I

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
4. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE
5. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederic
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem der UHH